InsidersTradesSigma
GYRE THERAPEUTICS, INC. Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the GYRE THERAPEUTICS, INC. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €764.8m. The latest transaction was disclosed on 11 June 2026 (Levée d'options). Among the most active insiders: Ma Songjiang. All data is accessible without an account.
58
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€771,487
45 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,703 of 28,200 companies
44.1
score / 100
Value25
Quality63
FCF yld-0.1%
Earn yld0.7%
EV/EBITDA53.1x
ROE-17%
Gross mgn95%
Net mgn4.3%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 June 2026
Declarations58 total
2,000 shares@ US$10.282.6% of flowCommon StockSEC:0001140361-25-020754:0
558 shares@ US$10.070.7% of flowCommon StockSEC:0001140361-25-020754:1
2,000 shares@ US$10.97Common StockSEC:0001140361-25-020474:0
182 shares@ US$10.24Common StockSEC:0001140361-25-020474:1
2,000 shares@ US$11.252.9% of flowCommon StockSEC:0001140361-25-020156:0
2,000 shares@ US$11.312.9% of flowCommon StockSEC:0001140361-25-019893:0
20 shares@ US$11.300.0% of flowCommon StockSEC:0001140361-25-019468:0
2,000 shares@ US$10.562.8% of flowCommon StockSEC:0001140361-25-018927:0
15,000 shares@ US$6.93100.0% of flowCommon StockSEC:0001140361-25-014601:0
174 shares@ US$10.000.2% of flowCommon StockSEC:0001140361-25-010234:0
2,000 shares@ US$10.132.7% of flowCommon StockSEC:0001140361-25-009877:0
2,000 shares@ US$12.093.2% of flowCommon StockSEC:0001140361-25-009424:0
2,000 shares@ US$11.803.2% of flowCommon StockSEC:0001140361-25-009017:0
2,000 shares@ US$11.403.1% of flowCommon StockSEC:0001140361-25-008623:0
53 shares@ US$13.030.1% of flowCommon StockSEC:0001140361-25-008091:0
25 of 58 declarations
About GYRE THERAPEUTICS, INC.
GYRE THERAPEUTICS, INC. is a company focused on developing innovative treatments for neurodegenerative diseases. It is listed on NASDAQ under the ticker GYRE.